During a recent Senate hearing, Dr. Erica Schwartz, nominated to lead the Centers for Disease Control and Prevention (CDC), faced inquiries regarding her stance on vaccine policy. The session took place on July 15, 2026. Dr. Schwartz, previously the deputy surgeon general under President Donald Trump’s administration, has been recognized for her support of vaccines.
Despite her background, questions arose concerning her awareness of Robert F. Kennedy Jr.’s recent changes in vaccine policy. Dr. Schwartz did not address these inquiries directly, leaving her position on these modifications unclear. Her hearing was part of the confirmation process for her appointment as director of the CDC.
This development has sparked interest, as Dr. Schwartz was previously considered a traditional choice for the role due to her vaccine advocacy. Her past experience in a significant public health position adds to the expectation that she would maintain a similar stance on vaccination policies moving forward.
Insights from a Hospital Executive’s Journey Working ER Shifts 
Biden Reflects on Memoir and Health Challenges 
Former Aide Criticizes Trump’s Advisers on Health Initiatives 
From Flight Attendant to Content Receptionist: Embracing Simplicity 
A Different Approach to Aging and Beauty 
Jocko Willink on Discipline and Longevity